Search results for "bioengineering"

showing 10 items of 1963 documents

Energy calibration of the NEXT-White detector with 1% resolution near Q ββ of 136Xe

2019

Excellent energy resolution is one of the primary advantages of electroluminescent high pressure xenon TPCs, and searches for rare physics events such as neutrinoless double-beta decay ($\beta\beta0\nu$) require precise energy measurements. Using the NEXT-White detector, developed by the NEXT (Neutrino Experiment with a Xenon TPC) collaboration, we show for the first time that an energy resolution of 1% FWHM can be achieved at 2.6 MeV, establishing the present technology as the one with the best energy resolution of all xenon detectors for $\beta\beta0\nu$ searches.

Nuclear and High Energy PhysicsPhysics - Instrumentation and DetectorsPhysical measurementsPhysics::Instrumentation and DetectorsDark Matter and Double Beta DecayFísica -- Mesuramentschemistry.chemical_elementBioengineeringAtomic01 natural sciencesMathematical SciencesNuclear physicsParticle and Plasma PhysicsXenonAffordable and Clean Energy0103 physical sciencesDark Matter and Double Beta Decay (experiments)CalibrationNuclearlcsh:Nuclear and particle physics. Atomic energy. RadioactivityCalibratge010306 general physicsMathematical PhysicsPhysicsQuantum Physics010308 nuclear & particles physicsDetectorResolution (electron density)MolecularDetectorsNuclear & Particles PhysicsFull width at half maximumchemistryBeta (plasma physics)Physical SciencesCalibrationlcsh:QC770-798High Energy Physics::ExperimentNeutrinoEnergy (signal processing)
researchProduct

Characterization of softwood and hardwood lignoboost kraft lignins with emphasis on their antioxidant activity

2014

Fractionation of softwood and hardwood LignoBoost kraft lignins, using sequential extraction with organic solvents of increasing hydrogen-bonding ability (dichloromethane, n-propanol, and methanol), was carried out. Using SEC, analytical pyrolysis, FTIR and UV/VIS spectroscopy, and chemical analytical methods, four fractions were obtained and characterized in terms of their yield, composition, functionality, lignin structural features, and antioxidant properties. In tests with free radicals (ABTS●+, DPPH●, O2●-) and the ORAC (oxygen radical absorbance capacity) assay, the high radical scavenging capacity of the lignin’s soluble fractions was demonstrated. The antioxidant activity of the fra…

ORAC assayEnvironmental EngineeringSoftwoodABTSOxygen radical absorbance capacityLignoBoost kraft ligninDPPHAntioxidant propertieslcsh:Biotechnologytechnology industry and agricultureBioengineeringmacromolecular substancesFractionationDPPH●chemistry.chemical_compoundchemistryABTS●+lcsh:TP248.13-248.65HardwoodOrganic chemistryLigninSolvent fractionationWaste Management and DisposalKraft paperO2●- assays
researchProduct

Real-time control strategy for nitrogen removal via nitrite in a SHARON reactor using pH and ORP sensors

2012

This paper presents a real-time control strategy for nitrogen removal via nitrite in a continuous flow SHARON reactor using on-line available and industrially feasible sensors (pH and ORP). The developed control strategy optimizes the length of aerobic and anoxic phases as well as the external carbon source addition. This strategy, implemented in a laboratory-scale SHARON reactor fed with synthetic wastewater and real dewatering sludge supernatant, was able to cope with step variations in influent flow rate and ammonium concentration. The main advantages of this control strategy over the traditional operation mode with fixed carbon source dosification and fixed length cycle operation were: …

ORPSHARONINGENIERIA HIDRAULICAChromatographypHchemistry.chemical_elementBioengineeringPulp and paper industryApplied Microbiology and BiotechnologyBiochemistryDewateringAnoxic watersFuzzy logicchemistry.chemical_compoundAmmoniachemistryWastewaterNitrogen removal via nitriteAmmoniumNitriteEffluentCarbonTECNOLOGIA DEL MEDIO AMBIENTE
researchProduct

Modeling the decay of nitrite oxidizing bacteria under different reduction potential conditions

2018

[EN] Autotrophic growth and decay rates of ammonium and nitrite oxidizing bacteria (AOB and NOB, respectively) have a significant impact on the design and on the process performance of wastewater treatment systems where nitrification occurs. Literature data on the separate decay rates of AOB and NOB is scarce and inconsistent. In this study, batch experiments based on respirometric techniques were conducted to determine the NOB decay rates under different oxidation-reduction potential conditions, in order to widen the understanding of nitrite dynamics. The decay rate measured under anoxic conditions was 85% lower than under aerobic conditions, whereas under anaerobic conditions the decay ra…

OUR RespirometryINGENIERIA HIDRAULICA0208 environmental biotechnologyBiomassBioengineering02 engineering and technology010501 environmental sciences01 natural sciencesApplied Microbiology and BiotechnologyBiochemistryAmmonia oxidizing bacteria (AOB)chemistry.chemical_compoundAmmoniumNitriteEffluentTECNOLOGIA DEL MEDIO AMBIENTE0105 earth and related environmental sciencesNitrite oxidizing bacteria (NOB)ChemistryAnoxic waters020801 environmental engineeringDecay rateActivated sludgeEnvironmental chemistryNitrificationSewage treatment
researchProduct

Optimization of a decellularized protocol of porcine tracheas. Long-term effects of cryopreservation. A histological study

2021

[EN] Objective: The aim of this study was to optimize a decellularization protocol in the trachea of Sus scrofa domestica (pig) as well as to study the effects of long-term cryopreservation on the extracellular matrix of decellularized tracheas. Methods: Porcine tracheas were decellularized using Triton X-100, SDC, and SDS alone or in combination. The effect of these detergents on the extracellular matrix characteristics of decellularized porcine tracheas was evaluated at the histological, biomechanical, and biocompatibility level. Morphometric approaches were used to estimate the effect of detergents on the collagen and elastic fibers content as well as on the removal of chondrocytes from …

OctoxynolSwine0206 medical engineeringTracheal stenosisBiomedical EngineeringMedicine (miscellaneous)Bioengineering02 engineering and technologyCryopreservationBiomaterialsAndrology03 medical and health sciences0302 clinical medicineMedicineSDSCryopreservationDecellularizationTissue EngineeringTissue Scaffoldsbusiness.industryTracheal histologyDecellularized tracheasAirway tissue engineeringGeneral Medicine020601 biomedical engineeringTracheal StenosisSus scrofa domesticaExtracellular MatrixTrachea030220 oncology & carcinogenesisFISICA APLICADAbusiness
researchProduct

Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer

2015

Abstract This review considers the potential utility of positron emission tomography (PET) tracers in the setting of response monitoring in breast cancer, with a special emphasis on glucose metabolic changes assessed with 18F-fluorodeoxyglucose (FDG). In the neoadjuvant setting of breast cancer, the metabolic response can predict the final complete pathologic response after the first cycles of chemotherapy. Because tumor metabolic behavior highly depends on cancer subtype, studies are ongoing to define the optimal metabolic criteria of tumor response in each subtype. The recent multicentric randomized AVATAXHER trial has suggested, in the human epidermal growth factor 2-positive subtype, a …

OncologyCancer Researchmedicine.medical_specialtyPathologyResponse to therapyReceptor ErbB-2medicine.medical_treatmentBreast Neoplasms[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineHealth outcomesTumor response030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineBreast cancerFluorodeoxyglucose F18Internal medicineBreast CancerHumansMedicineskin and connective tissue diseasesComputingMilieux_MISCELLANEOUSChemotherapymedicine.diagnostic_testbusiness.industryTumor biologyCancerPrognosismedicine.disease3. Good healthRadiographyOncologyPositron emission tomographyPositron-Emission Tomography030220 oncology & carcinogenesisFemalebusiness
researchProduct

Positron emission tomography and neoadjuvant therapy of breast cancer

2011

The increasing use of neoadjuvant therapy for breast cancer has led to the development of early surrogate markers of response. Positron emission tomography (PET) allows noninvasive study of fundamental biologic processes in the tumor; furthermore, PET provides various markers to assess tumor response early in the course of therapy. Numerous studies have shown that changes in tumor glucose metabolism during therapy are significantly correlated with final response and patient outcome. Moreover, new PET tracers that are currently being developed or under evaluation, providing specific information on tumor characteristics or receptor expression, will assist the development of new targeted antic…

OncologyCancer Researchmedicine.medical_treatmentReceptor expressionTumor response030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicineAntineoplastic Agent0302 clinical medicineMonoclonalPet tracerHumanizedAdjuvantNeoadjuvant therapyComputingMilieux_MISCELLANEOUSAntibodies Monoclonal Humanized; Antineoplastic Agents; Biomarkers Tumor; Breast Neoplasms; Chemotherapy Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Trastuzumab; Neoadjuvant Therapy; Positron-Emission Tomography; Cancer Research; Oncology; Medicine (all)Tumormedicine.diagnostic_testMedicine (all)General MedicineNeoadjuvant Therapy3. Good healthOncologyChemotherapy AdjuvantPositron emission tomography030220 oncology & carcinogenesisRadiopharmaceuticalFemaleBreast NeoplasmHumanmedicine.medical_specialtyAntineoplastic AgentsBreast Neoplasms[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineAntibodies Monoclonal HumanizedAntibodies[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciencesBreast cancerFluorodeoxyglucose F18Internal medicineBiomarkers TumormedicineChemotherapyHumansbusiness.industryTrastuzumabmedicine.diseasePositron-Emission TomographyRadiopharmaceuticalsbusinessBiomarkers
researchProduct

Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer

2016

International audience; Background: To determine whether dose/volume specific endpoints (DVSE) or Area under the rectal DVH curve (rAUC) better predict acute gastrointestinal (GI) toxicity in prostate cancer patients treated with IMRT in the era of daily image guidance (IG-IMRT). Methods: A set of DVSE was recorded from V25 to V75 (increments of 5Gy) (both in % and in cc) for 180 men. The rAUC was calculated for doses ranging between 25Gy and 50Gy (rAUC(25-50)). Univariate and multivariate logistic regressions were performed to determine the relationship between DVSE or rAUC(25-50) and the appearance of any acute GI toxicity. Results: The rates of acute grade 1 (G1), G2 and G3 GI toxicities…

OncologyMale[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatmentGastroenterology030218 nuclear medicine & medical imaging[ SDV.CAN ] Life Sciences [q-bio]/Cancer[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicineProstate cancer0302 clinical medicineProstateLarge intestineConformal Radiation-Therapy[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingAged 80 and overGastrointestinal tractProstate cancerRadiotherapy DosageMiddle Aged3. Good healthmedicine.anatomical_structureImpactOncologyRadiology Nuclear Medicine and imaging030220 oncology & carcinogenesisArea Under CurveToxicityImage Guidancemedicine.medical_specialtyRectum[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciencesInternal medicinemedicineBiochemical ControlHumansRadiology Nuclear Medicine and imagingRadiation InjuriesAgedRadiotherapybusiness.industryResearchRectumProstatic Neoplasmsmedicine.diseaseRadiation therapyAcute rectal toxicity predictive factorLogistic ModelsRadiotherapy Intensity-ModulatedbusinessAbsolute volumeRadiation Oncology (London, England)
researchProduct

18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer

2016

International audience; Previous studies have suggested that early changes in blood flow (BF) in response to neoadjuvant chemotherapy and evaluated with 150-water are a surrogate biomarker of outcome in women with breast cancer. This study investigates, in the triple-negative breast cancer subtype, the prognostic relevance of tumor BF changes (Delta BF) in response to chemotherapy, assessed using a short dynamic F-18-FDG PET acquisition. Methods: Forty-six consecutive women with triple-negative breast cancer and an indication for neoadjuvant chemotherapy were prospectively included. Women benefited from a baseline F-18-FDG PET examination with a 2-min chest-centered dynamic acquisition, sta…

Oncologymedicine.medical_specialtyPrognostic-FactorsBevacizumabSurvival[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatment[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineperfusion[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerInternal medicineMedicineblood flowRadiology Nuclear Medicine and imaging[ SDV.IB ] Life Sciences [q-bio]/BioengineeringTomography[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingNeoadjuvant therapyTriple-negative breast cancerSubtypesMarkersChemotherapytriple-negativemedicine.diagnostic_testbusiness.industryTriple Negative Breast Neoplasmsmedicine.disease3. Good healthBevacizumabPETMetabolismPositron emission tomography030220 oncology & carcinogenesisBiomarker (medicine)Pathological Response[SDV.IB]Life Sciences [q-bio]/BioengineeringAngiogenesisTherapybusinessmedicine.drug
researchProduct

Association de radiothérapie externe et de curiethérapie pour les cancers de la prostate

2017

International audience; Brachytherapy as sole treatment is standard of care for D’Amico classification low-risk prostate cancer. For intermediate and high-risk patients, brachytherapy can be associated to external beam radiation therapy to better take into account the risk of extracapsular effraction and/or seminal vesicle involvement. Three randomized studies have shown that this association increases freedom from relapse survival compared to exclusive external beam radiation therapy. This benefit is not shown for overall survival. The addition of a hormonal therapy to this association is most likely mandatory for high-risk patients, and needs to be confirmed for intermediate risk patients…

Oncologymedicine.medical_specialtyStandard of caremedicine.medical_treatmentBrachytherapyBrachytherapy[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine030218 nuclear medicine & medical imaging[ SDV.CAN ] Life Sciences [q-bio]/Cancer[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciencesProstate cancer0302 clinical medicineProstateInternal medicineMedicineRadiology Nuclear Medicine and imagingBoostRadiothérapieCancerGynecologyRadiotherapybusiness.industryGenitourinary systemProstateCancermedicine.disease3. Good healthRadiation therapymedicine.anatomical_structureOncology030220 oncology & carcinogenesisCuriethérapieHormonal therapybusiness
researchProduct